NewAmsterdam Pharma (NAMS) Wins EU Approvals. Can Cholesterol Pills Drive Royalties?
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) has cleared a major regulatory hurdle. On September 21, it announced European Commission approval of […]
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) has cleared a major regulatory hurdle. On September 21, it announced European Commission approval of […]
Interparfums, Inc. (NASDAQ:IPAR) and Marquee Brands announced on September 17 that their exclusive worldwide fragrance license for Roberto Cavalli and
Hudson Technologies, Inc. (NASDAQ:HDSN) announced on September 17 that it had signed a joint development agreement with Icorium to commercialize
Churchill Downs Incorporated (NASDAQ:CHDN) priced a $500 million senior secured term loan due in 2033 on September 17. The borrowing
Atlanticus Holdings Corporation (NASDAQ:ATLC) announced September 17 that it had completed the sale of CAR, its entire Auto Finance segment,
Shopify (NYSE: SHOP) shares rose roughly 8% on 22 September 2026 after Meta’s Muse AI agent gained the ability to
Leonardo DRS, Inc. (NASDAQ:DRS) announced September 17 that it had signed a contract with Doosan Enerbility to supply electric propulsion
Innate Pharma S.A. (NASDAQ:IPHA) reported a €19.6 million first-half net loss on September 17, following the closing of its lacutamab
Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced five-year ALIGN3D results on September 17, adding longer-term evidence for the Lapiplasty bunion-correction procedure.
Pinterest, Inc. (NYSE:PINS) announced Visual Search Ads on September 17, giving advertisers a new way to reach users considering purchases.